Karnataka Bank Appoints Biji Sreekrishnavilas as Interim MD & CEO

Karnataka Bank has appointed Biji Sreekrishnavilas Sankaranarayanan as its interim Managing Director and Chief Executive Officer (MD & CEO). Her appointment will be for a period of two months or until a full-time or regular MD & CEO assumes charge, whichever is earlier.
The bank announced the appointment in a regulatory communication, stating that the decision is aimed at ensuring leadership continuity and smooth functioning of its operations during the interim period.
Sankaranarayanan is currently serving as the Executive Director of Karnataka Bank. She brings more than 31 years of extensive banking experience, with expertise spanning various areas of banking operations, particularly across South Indian banks.
Her professional experience includes corporate banking, retail banking, branch banking, liability management, secured assets, business transformation and digital modernisation. Her diverse experience across key banking functions is expected to support the lender's strategic priorities and operational objectives during her tenure.
Also Read: Oister Global Launches Deep-Tech Fund With Rs.600 Crore Corpus
Commenting on the appointment, Karnataka Bank expressed confidence in her leadership capabilities and professional expertise.
“Karnataka Bank is confident that Mrs. Biji S S's expertise and leadership will drive the bank towards continued growth and success,” the lender said in its release.
Also Read: India, Egypt to Boost Trade, Address Non-Tariff Barriers
The appointment comes as the bank looks to maintain continuity in its leadership while the process of appointing a regular MD & CEO remains underway.
With over three decades of experience in the banking sector and her current role as Executive Director, Sankaranarayanan is expected to provide strategic direction and oversee the bank's operations during the interim period.
Also Read: Hindustan Zinc Approves Rs.80,000 Crore to Double Metal Capacity
Her appointment is effective November 16 and will remain in force until January 15, 2027, subject to the earlier assumption of charge by a regular MD & CEO.